Clinical Trial Update: Allogeneic Transplantation in Patients With Cutaneous T-Cell Lymphoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating allogeneic transplantation in patients with cutaneous T-cell lymphoma has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cutaneous T-cell Lymphoma
• Lymphoma

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Lymphoma, Disorder Related to Bone Marrow Transplantation | Phase 2 | Status: COMPLETED | Results posted: 2020-12-29